Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

Recruiting now · Not applicable

Conditions studied: Primary Progressive Aphasia, Dementia, Dementia, Frontotemporal, Alzheimer Disease, Neurodegenerative Diseases, Frontotemporal Lobar Degeneration, Apraxia, Motor, Dysarthria, Communication Disorders, Language Disorders, Speech Disorders, Neurocognitive Disorders, Aphasia, Bilingual Aphasia

In brief

Difficulties with speech and language are the first and most notable symptoms of primary progressive aphasia (PPA). While there is evidence that demonstrates positive effects of speech-language treatment for individuals with PPA who only speak one language (monolinguals), there is a significant need for investigating the effects of treatment that is optimized for bilingual speakers with PPA. This stage 2 efficacy clinical trial seeks to establish the effects of culturally and linguistically tailored speech-language interventions administered to bilingual individuals with PPA. The overall aim of the intervention component of this study is to establish the relationships between the bilingual experience (e.g., how often each language is used, how "strong" each language is) and treatment response of bilinguals with PPA. Specifically, the investigators will evaluate the benefits of tailored speech-language intervention administered in both languages to bilingual individuals with PPA (60 individuals will be recruited). The investigators will conduct an assessment before treatment, after treatment and at two follow-ups (6 and 12-months post-treatment) in both languages. When possible, a structural scan of the brain (magnetic resonance image) will be collected before treatment in order to identify if brain regions implicated in bilingualism are associated with response to treatment. In addition to the intervention described herein, 30 bilingual individuals with PPA will be recruited to complete behavioral cognitive-linguistic testing and will not receive intervention. Results will provide important knowledge about the neural mechanisms of language re-learning and will address how specific characteristics of bilingualism influence cognitive reserve and linguistic resilience in PPA.

Key facts

Study ID: NCT05741853
Run by: Stephanie Grasso
People needed: 60
Starts: 2023-05-01
Expected to finish: 2027-11-30
Last updated by the study team: 2026-06-10

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Meets diagnostic criteria for Primary Progressive Aphasia (PPA; Gorno-Tempini et al., 2011)
Bilingual in Spanish and Catalan or bilingual in Spanish and English
Different proficiency levels across languages are expected, any prior experience in both languages is acceptable
Intervention study: Score of 15 or higher on the Mini-Mental State Examination
Note that this project will also recruit individuals to participate in assessment only, for these individuals the following inclusion criteria applies: Score of 10 or higher on the Mini-Mental State Examination

You may not qualify if…

Other central nervous system or medical diagnosis that can cause symptoms
Other psychiatric diagnosis that can cause symptoms
Significant, uncorrected visual or hearing impairment that would interfere with participation
Prominent initial non-speech-language impairments (cognitive, behavioral, motoric)
Intervention Study: Score of less than 15 on the Mini-Mental State Examination
Note that this project will also recruit individuals to participate in assessment only, for these individuals the following inclusion criteria applies: Score of less than 10 on the Mini-Mental State Examination

Where it is running

University of Texas at Austin — Austin, Texas, United States (enrolling)
Hospital de la Santa Creu i Sant Pau — Barcelona, Barcelona, Spain (enrolling)
Hospital Clínic de Barcelona — Barcelona, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.